+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Aptamer Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025

  • ID: 4851987
  • Report
  • March 2018
  • Region: Global
  • 170 pages
  • Transparency Market Research
1 of 2

Global Aptamer Market: Overview

Aptamers are special class of molecules that combine the advantages of both low molecular weight and protein molecules. These molecules have attracted the attention of several researchers working in various areas of science ranging from medicine to analytical chemistry. Aptamers illustrate lock-and-key relationship between aptamer molecules and binding partners i.e., target molecules. The procedure commonly used for the selection of aptamers for a specific target molecule is known as SELEX process.

The global aptamer market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on material type, selection technique, application and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global aptamer market.

Global Aptamer Market: Key Segments

Based on material type the global aptamer market is segmented into nucleic acid aptamer and peptide aptamer. The material type segments have been analyzed based on type of aptamer uses for different application in the region. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. According to application the global aptamer market is segmented into research, diagnostics, therapeutics and others. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Aptamer Market: Regional Outlook

Geographically, the global aptamer market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, France, Italy, Spain and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico and Rest of Latin America) and Rest of World. The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the aptamer market are include AM Biotech, Aptagen, LLC., Aptamer Group, Aptamer Sciences, Inc., Base Pair Biotechnologies, CD Genomics, NeoVentures Biotechnology Inc., NAXXON Pharma, Aptus Biotech, TriLink BioTechnologies, LLC., and Pfizer Inc. among others.

Note: Product cover images may vary from those shown
2 of 2
Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Chapter 2. Assumptions and Research Methodology

Chapter 3. Executive Summary : Global Aptamer Market

Chapter 4. Market Overview
4.1. Introduction
4.1.1. Product Overview
4.1.2. Industry Evolution/Developments
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Pipeline Analysis - Aptamer Market
4.4. Porter’s Five Force Representation
4.5. Global Aptamer Market Analysis and Forecasts, 2015-2025
4.5.1. Market Revenue Projection (US$ Mn)
4.5.2. Market Outlook
4.6. Key Trends

Chapter 5. Global Aptamer Market Analysis and Forecasts, By Material Type
5.1. Key Findings/Developments
5.2. Introduction & Definition
5.3. Market Value Forecast By Material Type, 2016-2025
5.3.1. Nucleic acid Aptamer
5.3.2. Peptide Aptamer
5.4. Market Attractiveness By Material Type

Chapter 6. Global Aptamer Market Analysis and Forecasts, By Selection Technique
6.1. Key Findings/Developments
6.2. Introduction & Definition
6.3. Market Value and Volume Forecast By Selection Technique, 2016-2025
6.3.1. SELEX Technique
6.3.2. Others
6.4. Market Attractiveness By Selection Technique

Chapter 7. Global Aptamer Market Analysis and Forecasts, By Application
7.1. Key Findings/Developments
7.2. Introduction & Definition
7.3. Market Value and Volume Forecast By Application, 2017-2025
7.3.1. Research
7.3.2. Diagnostics
7.3.3. Therapeutics
7.3.4. Others
7.4. Market Attractiveness By Application

Chapter 8. Global Aptamer Market Analysis and Forecasts, By Geography/Region
8.1. Geographical Representation
8.2. Market Value and Volume Forecast By Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Rest of World
8.3. Market Attractiveness By Region
8.4. Key Trends

Chapter 9. North America Aptamer Market Analysis and Forecast
9.1. Market Value Forecast By Country , 2017-2025
9.1.1. U.S.
9.1.2. Canada
9.2. Market Value Forecast By Material Type, 2016-2025
9.3. Market Value Forecast By Selection Technique, 2016-2025
9.4. Market Value Forecast By Application, 2016-2025
9.5. Market Attractiveness Analysis
9.5.1. By Country
9.5.2. By Material Type
9.5.3. By Selection Technique
9.5.4. By Application
9.6. Key Trends

Chapter 10. Europe Aptamer Market Analysis and Forecast
10.1. Market Value Forecast By Country , 2017-2025
10.1.1. Germany
10.1.2. France
10.1.3. U.K.
10.1.4. Spain
10.1.5. Italy
10.1.6. Rest of Europe
10.2. Market Value Forecast By Material Type, 2016-2025
10.3. Market Value Forecast By Selection Technique, 2016-2025
10.4. Market Value Forecast By Application, 2016-2025
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Material Type
10.5.3. By Selection Technique
10.5.4. By Application
10.6. Key Trends

Chapter 11. Asia Pacific Aptamer Market Analysis and Forecast
11.1. Market Value Forecast By Country , 2017-2025
11.1.1. China
11.1.2. Japan
11.1.3. India
11.1.4. Australia & New Zealand
11.1.5. Rest of APAC
11.2. Market Value Forecast By Material Type, 2016-2025
11.3. Market Value Forecast By Selection Technique, 2016-2025
11.4. Market Value Forecast By Application, 2016-2025
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Material Type
11.5.3. By Selection Technique
11.5.4. By Application
11.6. Key Trends

Chapter 12. Latin America Aptamer Market Analysis and Forecast
12.1. Market Value Forecast By Country, 2017-2025
12.1.1. Brazil
12.1.2. Mexico
12.1.3. Rest of LATAM
12.2. Market Value Forecast By Material Type, 2016-2025
12.3. Market Value Forecast By Selection Technique, 2016-2025
12.4. Market Value Forecast By Application, 2016-2025
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Material Type
12.5.3. By Selection Technique
12.5.4. By Application
12.6. Key Trends

Chapter 13. Rest of World Aptamer Market Analysis and Forecast
13.1. Market Value Forecast By Material Type, 2016-2025
13.2. Market Value Forecast By Selection Technique, 2016-2025
13.3. Market Value Forecast By Application, 2016-2025
13.4. Market Attractiveness Analysis
13.4.1. By Material Type
13.4.2. By Selection Technique
13.4.3. By Application
13.5. Key Trends

Chapter 14. Competition Landscape
14.1. Competition Matrix
14.2. Company Profiles
14.2.1. AM Biotech. (HQ, Business Segments, Employee Strength)
14.2.1.1. Company Details
14.2.1.2. Company Description
14.2.1.3. Business Overview
14.2.1.4. SWOT Analysis
14.2.1.5. Financial Analysis
14.2.1.6. Strategic Overview
14.2.2. Aptagen, LLC. (HQ, Business Segments, Employee Strength)
14.2.2.1. Company Details
14.2.2.2. Company Description
14.2.2.3. Business Overview
14.2.2.4. SWOT Analysis
14.2.2.5. Strategic Overview
14.2.3. Aptamer Group (HQ, Business Segments, Employee Strength)
14.2.3.1. Company Details
14.2.3.2. Company Description
14.2.3.3. Business Overview
14.2.3.4. SWOT Analysis
14.2.3.5. Strategic Overview
14.2.4. Aptamer Science, Inc. (HQ, Business Segments, Employee Strength)
14.2.4.1. Company Details
14.2.4.2. Company Description
14.2.4.3. Business Overview
14.2.4.4. SWOT Analysis
14.2.4.5. Strategic Overview
14.2.5. Pfizer Inc. (HQ, Business Segments, Employee Strength)
14.2.5.1. Company Details
14.2.5.2. Company Description
14.2.5.3. Business Overview
14.2.5.4. SWOT Analysis
14.2.5.5. Financial Analysis
14.2.5.6. Strategic Overview
14.2.6. Base Pair Biotechnologies (HQ, Business Segments, Employee Strength)
14.2.6.1. Company Details
14.2.6.2. Company Description
14.2.6.3. Business Overview
14.2.6.4. SWOT Analysis
14.2.6.5. Financial Analysis
14.2.6.6. Strategic Overview
14.2.7. CD Genomics (HQ, Business Segments, Employee Strength)
14.2.7.1. Company Details
14.2.7.2. Company Description
14.2.7.3. Business Overview
14.2.7.4. SWOT Analysis
14.2.7.5. Financial Analysis
14.2.7.6. Strategic Overview
14.2.8. NeoVentures Biotechnology Inc. (HQ, Business Segments, Employee Strength)
14.2.8.1. Company Details
14.2.8.2. Company Description
14.2.8.3. Business Overview
14.2.8.4. SWOT Analysis
14.2.8.5. Financial Analysis
14.2.8.6. Strategic Overview
14.2.9. NAXXON Pharma (HQ, Business Segments, Employee Strength)
14.2.9.1. Company Details
14.2.9.2. Company Description
14.2.9.3. Business Overview
14.2.9.4. SWOT Analysis
14.2.9.5. Strategic Overview
14.2.10. Aptus Biotech (HQ, Business Segments, Employee Strength)
14.2.10.1. Company Details
14.2.10.2. Company Description
14.2.10.3. Business Overview
14.2.10.4. SWOT Analysis
14.2.10.5. Strategic Overview
14.2.11. TriLink Bio Technologies, LLC (HQ, Business Segments, Employee Strength)
14.2.11.1. Company Details
14.2.11.2. Company Description
14.2.11.3. Business Overview
14.2.11.4. SWOT Analysis
14.2.11.5. Strategic Overview
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll